These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12028454)

  • 1. Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy.
    Paueksakon P; Revelo MP; Ma LJ; Marcantoni C; Fogo AB
    Kidney Int; 2002 Jun; 61(6):2142-8. PubMed ID: 12028454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP; Federspiel C; Helderman H; Fogo AB
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group.
    Schwartz MM; Lewis EJ; Leonard-Martin T; Lewis JB; Batlle D
    Nephrol Dial Transplant; 1998 Oct; 13(10):2547-52. PubMed ID: 9794557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
    Ma LJ; Marcantoni C; Linton MF; Fazio S; Fogo AB
    Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats.
    Fujisawa G; Okada K; Muto S; Fujita N; Itabashi N; Kusano E; Ishibashi S
    Kidney Int; 2004 Oct; 66(4):1493-502. PubMed ID: 15458443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB
    Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
    Nicholas SB; Aguiniga E; Ren Y; Kim J; Wong J; Govindarajan N; Noda M; Wang W; Kawano Y; Collins A; Hsueh WA
    Kidney Int; 2005 Apr; 67(4):1297-307. PubMed ID: 15780082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X; Li C; Li X; Cai L
    Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2012 Jan; 17(1):68-75. PubMed ID: 21933307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1.
    Ma LJ; Nakamura S; Whitsitt JS; Marcantoni C; Davidson JM; Fogo AB
    Kidney Int; 2000 Dec; 58(6):2425-36. PubMed ID: 11115076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
    Yang HC; Ma LJ; Ma J; Fogo AB
    Kidney Int; 2006 May; 69(10):1756-64. PubMed ID: 16598202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of uPA on mesangial matrix changes in the kidney of diabetic rats.
    Cheng H; Chen C; Wang S
    Ren Fail; 2014 Sep; 36(8):1322-7. PubMed ID: 25010090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 in kidney pathology (Review).
    Małgorzewicz S; Skrzypczak-Jankun E; Jankun J
    Int J Mol Med; 2013 Mar; 31(3):503-10. PubMed ID: 23314920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephronectin expression in glomeruli of renal biopsy specimens from various kidney diseases: nephronectin is expressed in the mesangial matrix expansion of diabetic nephropathy.
    Nakatani S; Ishimura E; Mori K; Fukumoto S; Yamano S; Wei M; Emoto M; Wanibuchi H; Inaba M
    Nephron Clin Pract; 2012; 122(3-4):114-21. PubMed ID: 23689482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoxidation-modified macrophages and lipid peroxidation products are associated with the progression of human diabetic nephropathy.
    Uesugi N; Sakata N; Horiuchi S; Nagai R; Takeya M; Meng J; Saito T; Takebayashi S
    Am J Kidney Dis; 2001 Nov; 38(5):1016-25. PubMed ID: 11684555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic classification of diabetic nephropathy.
    Tervaert TW; Mooyaart AL; Amann K; Cohen AH; Cook HT; Drachenberg CB; Ferrario F; Fogo AB; Haas M; de Heer E; Joh K; Noël LH; Radhakrishnan J; Seshan SV; Bajema IM; Bruijn JA;
    J Am Soc Nephrol; 2010 Apr; 21(4):556-63. PubMed ID: 20167701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.